Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to α2-adrenoceptors in rat cerebral cortical membranes

David Wallace, Danny T. Muskardin, Nancy R. Zahniser

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Binding characteristics of α2-adrenoceptors in rat cerebral cortical membranes were compared using the antagonist radioligands [3H]idazoxan, [3H]2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline ([3H]RX821002), and the partial agonist radioligand [125I]2-[2,6-(dichloro-4-iodophenyl)imino]imidazoline ([125I]iodoclonidine). With [3H]RX821002 and α2-adrenoceptor subtype-selective competitors, both α2A/D- and α2C-adrenoceptor subtypes were detected, suggesting rat cortical membranes contain approximately 90% α2A/D-adronoceptor subtype and 10% α2C-adrenoceptor subtype. Only α2A/D-adrenoceptors were detected with [3H]idazoxan and [125I]iodoclonidine. All three radioligands bound to a single high affinity site (Kd = 0.3-1.6 nM). However, the densities of sites labeled by [3H]idazoxan and [125I]iodoclonidine were 50% greater than the density labeled by [3H]RX821002, likely representing non-adrenoceptor binding sites. The density of [125I]iodoclonidine binding sites in glycylglycine buffer was similar to that labeled by [3H]RX821002. These results suggest that: (1) α2A/D-adrenoceptors are the predominant subtype in rat cerebral cortex, (2) demonstrate that the small number of α2C-adrenoceptors in this tissue can be detected using prazosin to displace [3H]RX821002 binding, and (3) non-adrenoceptor binding with [125I]iodoclonidine can be minimized with the use of glycylglycine buffer.

Original languageEnglish
Pages (from-to)67-76
Number of pages10
JournalEuropean Journal of Pharmacology
Volume258
Issue number1-2
DOIs
StatePublished - 2 Jun 1994

Fingerprint

Idazoxan
Adrenergic Receptors
Pharmacology
Membranes
Glycylglycine
Buffers
Binding Sites
Imidazolines
Prazosin
2-methoxyidazoxan
4-iodoclonidine
Cerebral Cortex

Keywords

  • Cortex
  • Imidazoline
  • Non-adrenoceptor binding
  • α-Adrenoceptor

Cite this

@article{535d87d9184d4c86a3f4282a9bd1fd81,
title = "Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to α2-adrenoceptors in rat cerebral cortical membranes",
abstract = "Binding characteristics of α2-adrenoceptors in rat cerebral cortical membranes were compared using the antagonist radioligands [3H]idazoxan, [3H]2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline ([3H]RX821002), and the partial agonist radioligand [125I]2-[2,6-(dichloro-4-iodophenyl)imino]imidazoline ([125I]iodoclonidine). With [3H]RX821002 and α2-adrenoceptor subtype-selective competitors, both α2A/D- and α2C-adrenoceptor subtypes were detected, suggesting rat cortical membranes contain approximately 90{\%} α2A/D-adronoceptor subtype and 10{\%} α2C-adrenoceptor subtype. Only α2A/D-adrenoceptors were detected with [3H]idazoxan and [125I]iodoclonidine. All three radioligands bound to a single high affinity site (Kd = 0.3-1.6 nM). However, the densities of sites labeled by [3H]idazoxan and [125I]iodoclonidine were 50{\%} greater than the density labeled by [3H]RX821002, likely representing non-adrenoceptor binding sites. The density of [125I]iodoclonidine binding sites in glycylglycine buffer was similar to that labeled by [3H]RX821002. These results suggest that: (1) α2A/D-adrenoceptors are the predominant subtype in rat cerebral cortex, (2) demonstrate that the small number of α2C-adrenoceptors in this tissue can be detected using prazosin to displace [3H]RX821002 binding, and (3) non-adrenoceptor binding with [125I]iodoclonidine can be minimized with the use of glycylglycine buffer.",
keywords = "Cortex, Imidazoline, Non-adrenoceptor binding, α-Adrenoceptor",
author = "David Wallace and Muskardin, {Danny T.} and Zahniser, {Nancy R.}",
year = "1994",
month = "6",
day = "2",
doi = "10.1016/0014-2999(94)90058-2",
language = "English",
volume = "258",
pages = "67--76",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to α2-adrenoceptors in rat cerebral cortical membranes. / Wallace, David; Muskardin, Danny T.; Zahniser, Nancy R.

In: European Journal of Pharmacology, Vol. 258, No. 1-2, 02.06.1994, p. 67-76.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to α2-adrenoceptors in rat cerebral cortical membranes

AU - Wallace, David

AU - Muskardin, Danny T.

AU - Zahniser, Nancy R.

PY - 1994/6/2

Y1 - 1994/6/2

N2 - Binding characteristics of α2-adrenoceptors in rat cerebral cortical membranes were compared using the antagonist radioligands [3H]idazoxan, [3H]2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline ([3H]RX821002), and the partial agonist radioligand [125I]2-[2,6-(dichloro-4-iodophenyl)imino]imidazoline ([125I]iodoclonidine). With [3H]RX821002 and α2-adrenoceptor subtype-selective competitors, both α2A/D- and α2C-adrenoceptor subtypes were detected, suggesting rat cortical membranes contain approximately 90% α2A/D-adronoceptor subtype and 10% α2C-adrenoceptor subtype. Only α2A/D-adrenoceptors were detected with [3H]idazoxan and [125I]iodoclonidine. All three radioligands bound to a single high affinity site (Kd = 0.3-1.6 nM). However, the densities of sites labeled by [3H]idazoxan and [125I]iodoclonidine were 50% greater than the density labeled by [3H]RX821002, likely representing non-adrenoceptor binding sites. The density of [125I]iodoclonidine binding sites in glycylglycine buffer was similar to that labeled by [3H]RX821002. These results suggest that: (1) α2A/D-adrenoceptors are the predominant subtype in rat cerebral cortex, (2) demonstrate that the small number of α2C-adrenoceptors in this tissue can be detected using prazosin to displace [3H]RX821002 binding, and (3) non-adrenoceptor binding with [125I]iodoclonidine can be minimized with the use of glycylglycine buffer.

AB - Binding characteristics of α2-adrenoceptors in rat cerebral cortical membranes were compared using the antagonist radioligands [3H]idazoxan, [3H]2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline ([3H]RX821002), and the partial agonist radioligand [125I]2-[2,6-(dichloro-4-iodophenyl)imino]imidazoline ([125I]iodoclonidine). With [3H]RX821002 and α2-adrenoceptor subtype-selective competitors, both α2A/D- and α2C-adrenoceptor subtypes were detected, suggesting rat cortical membranes contain approximately 90% α2A/D-adronoceptor subtype and 10% α2C-adrenoceptor subtype. Only α2A/D-adrenoceptors were detected with [3H]idazoxan and [125I]iodoclonidine. All three radioligands bound to a single high affinity site (Kd = 0.3-1.6 nM). However, the densities of sites labeled by [3H]idazoxan and [125I]iodoclonidine were 50% greater than the density labeled by [3H]RX821002, likely representing non-adrenoceptor binding sites. The density of [125I]iodoclonidine binding sites in glycylglycine buffer was similar to that labeled by [3H]RX821002. These results suggest that: (1) α2A/D-adrenoceptors are the predominant subtype in rat cerebral cortex, (2) demonstrate that the small number of α2C-adrenoceptors in this tissue can be detected using prazosin to displace [3H]RX821002 binding, and (3) non-adrenoceptor binding with [125I]iodoclonidine can be minimized with the use of glycylglycine buffer.

KW - Cortex

KW - Imidazoline

KW - Non-adrenoceptor binding

KW - α-Adrenoceptor

UR - http://www.scopus.com/inward/record.url?scp=0028178238&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(94)90058-2

DO - 10.1016/0014-2999(94)90058-2

M3 - Article

C2 - 7925601

AN - SCOPUS:0028178238

VL - 258

SP - 67

EP - 76

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -